Search

Search Constraints

You searched for: Author/Creator Du, Feng

Search Results

3. Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors. Issue 1 (December 2016)